Parkman Healthcare Partners LLC Bicycle Therapeutics PLC Transaction History
Parkman Healthcare Partners LLC
- $678 Million
- Q2 2024
A detailed history of Parkman Healthcare Partners LLC transactions in Bicycle Therapeutics PLC stock. As of the latest transaction made, Parkman Healthcare Partners LLC holds 535,063 shares of BCYC stock, worth $12.4 Million. This represents 1.6% of its overall portfolio holdings.
Number of Shares
535,063
Previous 524,253
2.06%
Holding current value
$12.4 Million
Previous $13.1 Million
17.04%
% of portfolio
1.6%
Previous 1.77%
Shares
14 transactions
Others Institutions Holding BCYC
# of Institutions
111Shares Held
40.7MCall Options Held
3.4KPut Options Held
12.4K-
Baker Bros. Advisors LP New York, NY9.4MShares$218 Million2.53% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.49MShares$81 Million2.32% of portfolio
-
Ra Capital Management, L.P. Boston, MA2.25MShares$52.3 Million0.69% of portfolio
-
Fcpm Iii Services B.V. Naarden, P72.12MShares$49.3 Million6.34% of portfolio
-
Armistice Capital, LLC New York, NY1.97MShares$45.8 Million0.52% of portfolio
About BICYCLE THERAPEUTICS plc
- Ticker BCYC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,676,100
- Market Cap $689M
- Description
- Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...